Navigation Links
Eurofins Genomics Launches EXTREmers - Extremely Long Oligonucleotides
Date:12/12/2016

LOUISVILLE, Ky., Dec. 12, 2016 /PRNewswire/ -- Eurofins Genomics today announced the U.S. launch of its EXTREmer oligonucleotides, extremely long oligos that are developed using high-fidelity synthesis chemistry on the company's new DNA synthesis platform. Designed for synthetic biology, next-generation DNA sequencing and other growing applications, these oligos are provided at low yield and with low error rates, and can lead to increased success and reduced timelines in a range of everyday molecular biology experiments.

Among the benefits to researchers, EXTREmers allow for construction of genes with segments of low sequence variability that would be difficult or impossible to assemble using shorter oligos. They can also be used directly as a template for in vitro transcription of RNA molecules, saving time and effort for scientists who previously had to ligate smaller DNA oligos to form the template. In addition, they can be used for introducing large-scale or multi-site mutations without waiting days or weeks to go through multiple cycles of site-directed mutagenesis. The new service will also be helpful for generating oligos for DNA-directed RNA interference, capture probes, or control standards in qPCR experiments, among other demanding applications.

"EXTREmers are produced using our newly developed, high-throughput oligonucleotide synthesizer that incorporates highly efficient reagent delivery systems, cycle-optimization, and downstream processes to ensure that each coupling reaction achieves greater than 99.5% efficiency," said Jeff Nelson, Head of Process Development for High-Throughput Synthesis at Eurofins Genomics. "Our initial experiments have shown that these oligos offer a higher probability of success than those offered by comparable products when evaluated in cloning applications."

More information about EXTREmers is available at http://www.eurofinsgenomics.com/en/products/dnarna-synthesis/extremers.aspx.

About Eurofins Genomics

Eurofins Genomics company is an international provider of DNA sequencing services, genotyping services, DNA synthesis products, and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological, and research markets. Eurofins Genomics operates leading R&D and production sites in the USA, Canada, Germany, India, and Japan.

Eurofins Genomics is the genomic services brand of the Eurofins Group, the worldwide leader in food, environmental and pharmaceutical testing. With 25,000 staff in over 250 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

© Eurofins MWG Operon, LLC, a Eurofins Genomics Company

Contacts:

Media:

Nicole Litchfield
Bioscribe, Inc.
415-793-6468
nicole@bioscribe.com

Company:

James Corne
Eurofins Genomics
502-302-6351
jamescorne@eurofins.com

Logo - http://photos.prnewswire.com/prnh/20161004/415145LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eurofins-genomics-launches-extremers--extremely-long-oligonucleotides-300376190.html


'/>"/>
SOURCE Eurofins Genomics
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
2. SimpleSeq Webless by Eurofins MWG Operon for Order-Free DNA Sequencing
3. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
4. Eurofins MWG Operon, Inc. Names James Corne as Director of Marketing
5. Eurofins Pharma Discovery Services Launches New eCommerce Platform for Drug Discovery Products
6. Eurofins Microbiology Opens State-of-the-Art Laboratory in Louisville, KY
7. Eurofins Genomics Looks to Disrupt DNA Synthesis Market with Smaller-Scale, High-Throughput Service Featuring Rapid Turnaround and Lower Price
8. Clarification on Eurofins Scientific, Inc. (US) Announcement of the Appointment of Sean Murray
9. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
10. BGI-Shenzhen Completes Acquisition of Complete Genomics
11. Squished bug genomics: Insect goo aids biodiversity research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... Disappearing forests and ... lives of over 5.5 million people each year. Especially those living in larger cities ... Treepex - based in one of the most pollution-affected countries globally - decided to ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... , ... October 10, 2017 , ... Dr. Bob Harman, ... his local San Diego Rotary Club. The event entitled “Stem Cells ... and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):